Pro-Dex Shares Outstanding 2010-2024 | PDEX

Pro-Dex shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pro-Dex Annual Shares Outstanding
(Millions of Shares)
2023 4
2022 4
2021 4
2020 4
2019 4
2018 4
2017 4
2016 4
2015 4
2014 3
2013 3
2012 3
2011 3
2010 3
2009 3
Pro-Dex Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 4
2023-12-31 4
2023-09-30 4
2023-06-30 4
2023-03-31 4
2022-12-31 4
2022-09-30 4
2022-06-30 4
2022-03-31 4
2021-12-31 4
2021-09-30 4
2021-06-30 4
2021-03-31 4
2020-12-31 4
2020-09-30 4
2020-06-30 4
2020-03-31 4
2019-12-31 4
2019-09-30 4
2019-06-30 4
2019-03-31 4
2018-12-31 4
2018-09-30 4
2018-06-30 4
2018-03-31 4
2017-12-31 4
2017-09-30 4
2017-06-30 4
2017-03-31 4
2016-12-31 4
2016-09-30 4
2016-06-30 4
2016-03-31 4
2015-12-31 4
2015-09-30 4
2015-06-30 4
2015-03-31 4
2014-12-31 4
2014-09-30 4
2014-06-30 3
2014-03-31 3
2013-12-31 3
2013-09-30 3
2013-06-30 3
2013-03-31 3
2012-12-31 3
2012-09-30 3
2012-06-30 3
2012-03-31 3
2011-12-31 3
2011-09-30 3
2011-06-30 3
2011-03-31 3
2010-12-31 3
2010-09-30 3
2010-06-30 3
2010-03-31 3
2009-12-31 3
2009-09-30 3
2009-06-30 3
2009-03-31 3
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.066B $0.046B
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.876B 21.30
Becton Dickinson (BDX) United States $66.674B 18.86
West Pharmaceutical Services (WST) United States $23.973B 42.97
Cardinal Health (CAH) United States $23.239B 13.29
Align Technology (ALGN) United States $18.635B 35.98
Labcorp (LH) United States $18.251B 15.71
Cooper (COO) United States $17.949B 26.47
Henry Schein (HSIC) United States $8.655B 15.40
DENTSPLY SIRONA (XRAY) United States $5.567B 14.41
Merit Medical Systems (MMSI) United States $5.059B 27.73
CONMED (CNMD) United States $2.265B 20.54
STAAR Surgical (STAA) United States $2.252B 86.47
Patterson (PDCO) United States $2.228B 10.99
Atrion (ATRI) United States $0.803B 42.88
Lifevantage (LFVN) United States $0.081B 10.48